DC Chemicals

All products / DC9712

Iinerixibat
CAT. NO. DC9712

Iinerixibat

Pack sizes and prices

Pack sizePrice
100 mg$1,200 USDRequest a quote →
250 mg$1,900 USDRequest a quote →
1 g$3,900 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

GSK2330672 is a highly potent, nonabsorbable ASBT inhibitor with excellent aqueous solubility, selectivity, and developability properties for evaluation in safety studies and ultimately humans. GSK2330672 will be a valuable clinical tool for exploring the therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patients with type 2 diabetes. in vivo: GSK2330672 results in potent inhibition of ASBT and very low oral absorption in the rat. GSK2330672 shows potent mouse and rat ASBT activity and was stable in GI stability assays. GSK2330672 is stable in the rodent GI tract and potently induced fecal bile acid excretion in mice, leading us to select these three compounds for mechanistic and efficacy studies in vivo in lean rats and Zucker Diabetic Fatty (ZDF) rats, respectively.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC9712
Product nameIinerixibat
CAS1345982-69-5
Molecular formulaC28H38N2O7S
Molecular weight546.68
Purity>98%
SMILESO=C(O)CC(NCC1=C(OC)C=C(C2=C1)[C@@H](C3=CC=CC=C3)N[C@](CC)(CCCC)CS2(=O)=O)CC(O)=O

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Iinerixibat (DC9712)

Related research products